Vulnamin® products can be used as an adjuvant in the wound healing process.2,3,4,5
Vulnamin® products are available in four different presentations: a spray, a powder, a gel and a cream.


Vulnamin® Spray

Vulnamin® Spray has a preventative effect on the evolution of skin lesions and can be used to protect skin integrity.2

Vulnamin® Gel

Vulnamin® Gel can be used to help restore the microenvironment of the wound, promoting elimination of necrotic tissues and protecting skin integrity.4

Vulnamin® Powder

Vulnamin® Powder favours production of granulation tissue and the healing process.3

Vulnamin® Cream

Vulnamin® Cream facilitates regeneration of tissues and maintenance of the ideal moisture conditions of the wound to promote reepithelisation of cutaneous lesions.5

Wound aetiology


Wound aetiology can be accidental, intentional, or the result of a disease process. Wounds can range in depth from a break in the epithelial integrity of the skin, or can extend into subcutaneous tissue with damage to other structures such as tendons, muscles, vessels, nerves, parenchymal organs and bone.1

Depending on the length of time in which it takes them to heal, wounds will often be classified as acute or chronic.1

Impact of chronic wounds


Chronic wounds are a significant health problem that require adequate healthcare resource allocation. Chronic wounds can result in significant functional impairment, a reduction in patient quality of life, and increased financial costs for both the patient and the healthcare system.6


Wound complications are associated with longer and more intensive treatment, extended hospital stays, readmission and specialist medical or surgical intervention.7


In addition, chronic wounds have many psychosocial consequences including stress, negative mood, pain and social isolation. Care of chronic wounds such as dressing changes can negatively impact upon a patient’s daily routine through either taking time out to attend wound management procedures or through the wound dressing impacting upon daily activities.8

Vulnamin® products

What is
Vulnamin®?

Vulnamin® products are medical devices that can be used as an adjuvant in the wound healing process.2,3,4,5

Vulnamin® products are available in four presentations: a spray,  a powder, a gel and a cream.2,3,4,5

Vulnamin® Spray

Vulnamin® Spray has a preventative effect on the evolution of skin lesions and can be used to protect skin integrity. It facilitates the cleaning of the wound and formation of granulation tissue and therefore skin regeneration.

Vulnamin® Spray additionally reduces inflammatory infiltrate and stimulates fibroblast production of collagen 2

Vulnamin® Powder

Vulnamin® Powder favours production of granulation tissue and the healing process. It assists skin and connective tissue regeneration through the production of collagen.

Vulnamin® Powder favours the elimination of necrotic tissue and protects the integrity of skin.3

Vulnamin® Gel

Vulnamin® Gel can be used to help restore the microenvironment of the wound, promoting elimination of necrotic tissues and protecting skin integrity.

Vulnamin® Gel can be used to induce autolysis and stimulate granulation of vital underlying tissue.4

Vulnamin® Cream

Vulnamin® cream facilitates regeneration of tissues and maintenance of the ideal moisture conditions of the wound to promote reepithelialisation of cutaneous lesions.

It promotes the reconstruction of connective tissue and therefore the regeneration of epithelial cells.5

How does
Vulnamin®
work?

Vulnamin® induces re-epithelialisation of the wound, which is associated with a marked reduction in inflammatory infiltrate and colonisation of the lesion by newly formed vessels.11

Vulnamin® has been shown to significantly increase the coverage of wounds by granulation tissue12, even whilst debridement is underway.13

The use of Vulnamin® has not been associated with any adverse effects, intolerances or allergies.13

Vulnamin® has been clinically shown to induce a rapid and progressive reduction in wound size, and to reduce healing time of wounds.11,12,13,14

Wound size has been shown to be significantly reduced after 2 weeks of use, with a continued significant reduction after 614 and 10 weeks of use compared to baseline.11

Vulnamin® mechanism of action

Following clinical investigations, the image below demonstrates a possible mechanism of action for Vulnamin®.15